Αρχική Uncategorized Judge Rules That 3-Year-Old Child With Leukemia Must Get Chemo Against Parents’...

Judge Rules That 3-Year-Old Child With Leukemia Must Get Chemo Against Parents’ Wishes

Should parents still be able to control the type of medical treatment their child receives when they disagree with medical professionals?A Hillsborough County judge in a controversial case in Florida says no.Noah McAdams is a three-year-old boy with leukemia. After undergoing only two chemo treatments, his parents, Joshua McAdams (27) and Taylor Bland-Ball (22), pulled him out of the treatment.McAdams and Bland-Ball claim that the chemo gave Noah severe mood swings and even caused him to be violent.They fled the state to pursue alternative therapies.They were found in Kentucky and brought back to Florida, where they have temporarily lost custody of their son. Now Noah is in the custody of his grandparents, and a judge has ruled that he must continue with chemotherapy.
Photo: YouTube/10News WTSPNoah was diagnosed with leukemia in April and was being treated at John Hopkins All Children’s Hospital in St. Petersburg, Florida.However, only ten days after he began chemotherapy, they left the hospital. Bland-Ball says that they were told that there were no signs of any cancer cells left and that they had been allowed to leave.At that point, Bland-Ball began searching for a second opinion on Noah’s health, looking for a natural treatment option — something the hospital did not approve of.
Photo: YouTube/10News WTSPDuring an interview, Bland-Ball said they are going to fight the judge’s ruling.“We left and we went up to Kentucky,” she said. “We just wanted the time to get our second opinion.“This is not about whether we’re choosing natural therapies, alternative therapies. This is about our rights as parents to seek other options … I think it’s really important that people know that there are other options other than chemotherapy, and I think this really opened up a good discussion on parental rights, about patient rights.”
Photo: YouTube/10News WTSPThe standard course of treatment for this type of leukemia is chemotherapy for two and a half years. At this point, the judge has only mandated that Noah undergo the first phase of chemo, which lasts about a month.After that, Noah will be reevaluated by his doctors to check the progress of the cancer.In the meantime, his parents are allowed to have unsupervised visits with Noah and to use natural treatments, including medical marijuana.
Photo: YouTube/10News WTSPThe family attorney, Michael Minardi, said that Noah’s parents would like to treat Noah’s cancer with CBD oil, vitamins, a good diet, and medical marijuana.“While we were disappointed he has to start chemotherapy tomorrow,” he said, “we are encouraged the judge gives him an opportunity to use additional treatments to treat him, to not only help him have less side effects from the chemotherapy [but to] help kill the cancer.”The two opposing sides will meet again on June 4th to decide what comes next after this.Learn more in the video, and let us know what you think.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Քաղցկեղն իմ համայնքում՝ Քաղցկեղով երեխաների բուժումը Հայաստանում

«Քաղցկեղն իմ համայնքում»-ը Cancer.Net Blog շարքից է, որը ցույց է տալիս աշխարհում քաղցկեղի ազդեցությունը և թե ինչպես են մարդիկ աշխատում իրենց տարածաշրջանում քաղցկեղով մարդկանց...

Ovarian cancer screening trial did not save lives

“The effort from the start was to save lives of women with ovarian cancer. To build evidence for a screening programme that the NHS...

Cemiplimab Outperforms Investigator’s Choice Chemotherapy in the Second-Line Setting for Recurrent/Metastatic Cervical Carcinoma

Overall survival (OS) was significantly improved with cemiplimab as compared to investigator’s choice of chemotherapy in patients with recurrent/metastatic cervical cancer and progression after...

Expressive Writing, What is It?

One of psychotherapy’s main beliefs is that putting thoughts and feelings into words may produce mental health benefits. Of course, this also applies to cancer...

Sacituzumab Govitecan Earns Full Approval for Triple-Negative Breast Cancer

May 12, 2021, by NCI Staff In triple-negative breast cancer (TNBC), tumor cells don't have estrogen receptors (ER), progesterone receptors (PR), or large amounts of...

‘Will cancer make me infertile?’ – That Cancer Conversation

For the first episode of That Cancer Conversation, we explore infertility and cancer. From teenage body worries to an intercontinental surrogacy story, we chat to...